1) Strategic Focus and Leadership - IFF's Q1 2026 results demonstrate a commitment to execution and innovation amidst global market uncertainties. - The company is simplifying its portfolio, allowing for reinvestment in core growth areas and achieving deleveraging targets. - A significant divestiture of the commodity soy crush, concentrates, and lecithin business was completed for $110 million, with ongoing interest in the Food Ingredients business sale. - New production capabilities were added in Latin America to support Health & Biosciences growth.

2) Financial and Segment Results - Revenue exceeded $2.7 billion, marking a 3% sales growth driven by volume improvements across all segments. - Adjusted operating EBITDA rose to $568 million, an 8% increase, with an EBITDA margin of 20.7%, the highest since Q2 2022. - Segment performance highlights: - Taste: Sales increased 2% to $656 million, with an 18% rise in adjusted EBITDA to $153 million. - Food Ingredients: Sales grew 3% to $839 million, with a 12% increase in adjusted EBITDA to $114 million. - Health & Biosciences: Sales up 5% to $595 million, with adjusted EBITDA of $153 million, a 7% increase. - Scent: Sales rose 1% to $651 million, but adjusted EBITDA decreased 2% to $148 million due to unfavorable pricing pressures.

3) Challenges and Headwinds - Ongoing geopolitical tensions, particularly in the Middle East, are expected to create uncertainty and impact demand, especially in the Scent segment. - Inflationary pressures are anticipated to increase throughout 2026, affecting profitability in Q2 before easing in the latter half of the year. - The company is proactively addressing these challenges through pricing actions and customer collaboration.

4) Operational and Product Plans - IFF is focused on enhancing its innovation and commercial pipelines, with expectations for continued growth in the second half of 2026. - The company is committed to maintaining a disciplined capital allocation strategy, balancing share buybacks, R&D investments, and potential acquisitions. - A strong emphasis on productivity initiatives is in place to offset inflationary pressures and support margin improvements.

5) Guidance and Outlook - IFF reaffirms its 2026 sales guidance of $10.5 billion to $10.8 billion, reflecting 1% to 4% growth, and adjusted operating EBITDA guidance of $2.05 billion to $2.15 billion, representing 3% to 8% growth. - The company expects to navigate the uncertain macroeconomic environment while continuing to focus on its strategic goals.

Bottom line: IFF's Q1 results reflect solid execution and strategic progress, positioning the company to navigate challenges while reaffirming its full-year guidance. The focus on innovation, productivity, and disciplined capital allocation supports long-term value creation for shareholders.